These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18822517)

  • 1. Treating prostate cancer, Part V: radiation therapy.
    Harv Mens Health Watch; 2008 Sep; 13(2):1-4. PubMed ID: 18822517
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are organ preservation and maintenance of sexual function compatible with optimal management of prostate cancer? Part 2--Advanced cancer.
    Pavone-Macaluso M
    Prog Clin Biol Res; 1991; 370():203-5. PubMed ID: 1924452
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer (non-metastatic).
    Wilt T
    Clin Evid; 2003 Jun; (9):973-85. PubMed ID: 12967402
    [No Abstract]   [Full Text] [Related]  

  • 6. [High risk prostate cancer results of one year RT-HT].
    Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
    Woodward WA; Wachsberger P; Burd R; Dicker AP
    Prostate Cancer Prostatic Dis; 2005; 8(2):127-32. PubMed ID: 15643450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-only not dead?
    Chuba PJ; Aref A
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):329-30. PubMed ID: 16377423
    [No Abstract]   [Full Text] [Related]  

  • 9. Who, when, where, and how: salvage prostate cancer with radiotherapy.
    Chien CP; Roach M
    Oncology (Williston Park); 2010 Jul; 24(8):702, 704. PubMed ID: 20718249
    [No Abstract]   [Full Text] [Related]  

  • 10. Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer.
    Hurwitz MD
    Nat Clin Pract Oncol; 2008 Nov; 5(11):668-76. PubMed ID: 18825143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate cancer and sexuality].
    Mimoun S
    Soins; 2007 Mar; (713):48-9. PubMed ID: 17419574
    [No Abstract]   [Full Text] [Related]  

  • 12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
    Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric outcomes in prostate brachytherapy: is downsizing the prostate with androgen deprivation necessary?
    Gibbons EP; Jacobs BL; Smith RP; Beriwal S; Krishna K; Benoit RM
    Brachytherapy; 2009; 8(3):304-8. PubMed ID: 19217354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing prostate brachytherapy-related morbidity.
    Merrick GS; Wallner KE; Butler WM
    Urology; 2003 Nov; 62(5):786-92. PubMed ID: 14624895
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer (non-metastatic).
    Wilt T
    Clin Evid; 2003 Dec; (10):1023-38. PubMed ID: 15555136
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
    D'Amico AV
    J Clin Oncol; 2007 Jan; 25(1):8-9. PubMed ID: 17194901
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamic conformal arc radiotherapy with rectum hollow-out technique for localized prostate cancer.
    Tomita N; Kodaira T; Tachibana H; Nakamura T; Tomoda T; Nakahara R; Inokuchi H; Hayashi N; Fuwa N
    Radiother Oncol; 2009 Mar; 90(3):346-52. PubMed ID: 18950880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
    Chen RC; Sadetsky N; Chen MH; Carroll PR; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):36-9. PubMed ID: 19233568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conformal radiotherapy of prostate cancers].
    de Crevoisier R
    Soins; 2007 Mar; (713):40-1. PubMed ID: 17419569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.